Cargando…

Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters

PURPOSE: Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians using performance status (PS) assessments based on a descriptive scale, such as the Ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilanon, Tanachat, Nocera, Luciano P., Martin, Alexander S., Kolatkar, Anand, May, Marcella, Hasnain, Zaki, Ueno, Naoto T., Yennu, Sriram, Alexander, Angela, Mejia, Aaron E., Boles, Roger Wilson, Li, Ming, Lee, Jerry S. H., Hanlon, Sean E., Cozzens Philips, Frankie A., Quinn, David I., Newton, Paul K., Broderick, Joan, Shahabi, Cyrus, Kuhn, Peter, Nieva, Jorge J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531613/
https://www.ncbi.nlm.nih.gov/pubmed/32970482
http://dx.doi.org/10.1200/CCI.20.00023
_version_ 1783589789541335040
author Nilanon, Tanachat
Nocera, Luciano P.
Martin, Alexander S.
Kolatkar, Anand
May, Marcella
Hasnain, Zaki
Ueno, Naoto T.
Yennu, Sriram
Alexander, Angela
Mejia, Aaron E.
Boles, Roger Wilson
Li, Ming
Lee, Jerry S. H.
Hanlon, Sean E.
Cozzens Philips, Frankie A.
Quinn, David I.
Newton, Paul K.
Broderick, Joan
Shahabi, Cyrus
Kuhn, Peter
Nieva, Jorge J.
author_facet Nilanon, Tanachat
Nocera, Luciano P.
Martin, Alexander S.
Kolatkar, Anand
May, Marcella
Hasnain, Zaki
Ueno, Naoto T.
Yennu, Sriram
Alexander, Angela
Mejia, Aaron E.
Boles, Roger Wilson
Li, Ming
Lee, Jerry S. H.
Hanlon, Sean E.
Cozzens Philips, Frankie A.
Quinn, David I.
Newton, Paul K.
Broderick, Joan
Shahabi, Cyrus
Kuhn, Peter
Nieva, Jorge J.
author_sort Nilanon, Tanachat
collection PubMed
description PURPOSE: Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians using performance status (PS) assessments based on a descriptive scale, such as the Eastern Cooperative Oncology Group (ECOG) scale. Such assessments can be bias prone, resulting in PS score disagreements between assessors. We therefore propose to evaluate PS using physical activity measurements (eg, energy expenditure) from wearable activity trackers. Specifically, we examined the feasibility of using a wristband (band) and a smartphone app for PS assessments. METHODS: We conducted an observational study on a cohort of patients with solid tumor receiving highly emetogenic chemotherapy. Patients were instructed to wear the band for a 60-day activity-tracking period. During clinic visits, we obtained ECOG scores assessed by physicians, coordinators, and patients themselves. UHEs occurring during the activity-tracking period plus a 90-day follow-up period were later compiled. We defined our primary outcome as the percentage of patients adherent to band-wear ≥ 80% of 10 am to 8 pm for ≥ 80% of the activity-tracking period. In an exploratory analysis, we computed hourly metabolic equivalent of task (MET) and counted 10 am to 8 pm hours with > 1.5 METs as nonsedentary physical activity hours. RESULTS: Forty-one patients completed the study (56.1% female; 61.0% age 40-60 years); 68% were adherent to band-wear. ECOG score disagreement between assessors ranged from 35.3% to 50.0%. In our exploratory analysis, lower average METs and nonsedentary hours, but not higher ECOG scores, were associated with higher 150-day UHEs. CONCLUSION: The use of a wearable activity tracker is generally feasible in a similar population of patients with cancer. A larger randomized controlled trial should be conducted to confirm the association between lower nonsedentary hours and higher UHEs.
format Online
Article
Text
id pubmed-7531613
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-75316132021-09-24 Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters Nilanon, Tanachat Nocera, Luciano P. Martin, Alexander S. Kolatkar, Anand May, Marcella Hasnain, Zaki Ueno, Naoto T. Yennu, Sriram Alexander, Angela Mejia, Aaron E. Boles, Roger Wilson Li, Ming Lee, Jerry S. H. Hanlon, Sean E. Cozzens Philips, Frankie A. Quinn, David I. Newton, Paul K. Broderick, Joan Shahabi, Cyrus Kuhn, Peter Nieva, Jorge J. JCO Clin Cancer Inform ORIGINAL REPORTS PURPOSE: Unplanned health care encounters (UHEs) such as emergency room visits can occur commonly during cancer chemotherapy treatments. Patients at an increased risk of UHEs are typically identified by clinicians using performance status (PS) assessments based on a descriptive scale, such as the Eastern Cooperative Oncology Group (ECOG) scale. Such assessments can be bias prone, resulting in PS score disagreements between assessors. We therefore propose to evaluate PS using physical activity measurements (eg, energy expenditure) from wearable activity trackers. Specifically, we examined the feasibility of using a wristband (band) and a smartphone app for PS assessments. METHODS: We conducted an observational study on a cohort of patients with solid tumor receiving highly emetogenic chemotherapy. Patients were instructed to wear the band for a 60-day activity-tracking period. During clinic visits, we obtained ECOG scores assessed by physicians, coordinators, and patients themselves. UHEs occurring during the activity-tracking period plus a 90-day follow-up period were later compiled. We defined our primary outcome as the percentage of patients adherent to band-wear ≥ 80% of 10 am to 8 pm for ≥ 80% of the activity-tracking period. In an exploratory analysis, we computed hourly metabolic equivalent of task (MET) and counted 10 am to 8 pm hours with > 1.5 METs as nonsedentary physical activity hours. RESULTS: Forty-one patients completed the study (56.1% female; 61.0% age 40-60 years); 68% were adherent to band-wear. ECOG score disagreement between assessors ranged from 35.3% to 50.0%. In our exploratory analysis, lower average METs and nonsedentary hours, but not higher ECOG scores, were associated with higher 150-day UHEs. CONCLUSION: The use of a wearable activity tracker is generally feasible in a similar population of patients with cancer. A larger randomized controlled trial should be conducted to confirm the association between lower nonsedentary hours and higher UHEs. American Society of Clinical Oncology 2020-09-24 /pmc/articles/PMC7531613/ /pubmed/32970482 http://dx.doi.org/10.1200/CCI.20.00023 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle ORIGINAL REPORTS
Nilanon, Tanachat
Nocera, Luciano P.
Martin, Alexander S.
Kolatkar, Anand
May, Marcella
Hasnain, Zaki
Ueno, Naoto T.
Yennu, Sriram
Alexander, Angela
Mejia, Aaron E.
Boles, Roger Wilson
Li, Ming
Lee, Jerry S. H.
Hanlon, Sean E.
Cozzens Philips, Frankie A.
Quinn, David I.
Newton, Paul K.
Broderick, Joan
Shahabi, Cyrus
Kuhn, Peter
Nieva, Jorge J.
Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters
title Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters
title_full Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters
title_fullStr Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters
title_full_unstemmed Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters
title_short Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters
title_sort use of wearable activity tracker in patients with cancer undergoing chemotherapy: toward evaluating risk of unplanned health care encounters
topic ORIGINAL REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531613/
https://www.ncbi.nlm.nih.gov/pubmed/32970482
http://dx.doi.org/10.1200/CCI.20.00023
work_keys_str_mv AT nilanontanachat useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT noceralucianop useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT martinalexanders useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT kolatkaranand useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT maymarcella useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT hasnainzaki useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT uenonaotot useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT yennusriram useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT alexanderangela useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT mejiaaarone useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT bolesrogerwilson useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT liming useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT leejerrysh useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT hanlonseane useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT cozzensphilipsfrankiea useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT quinndavidi useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT newtonpaulk useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT broderickjoan useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT shahabicyrus useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT kuhnpeter useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters
AT nievajorgej useofwearableactivitytrackerinpatientswithcancerundergoingchemotherapytowardevaluatingriskofunplannedhealthcareencounters